ImmunOs Therapeutics

About:

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Website: http://www.immunostherapeutics.com

Top Investors: Mission BioCapital, Lightspeed Venture Partners, European Union, Innosuisse, Samsara BioCapital

Description:

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Total Funding Amount:

$102M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Schlieren, Zurich, Switzerland

Founded Date:

2014-01-01

Contact Email:

info(AT)immunostherapeutics.com

Founders:

Osiris Marroquin Belaunzaran

Number of Employees:

11-50

Last Funding Date:

2024-09-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai